working
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why next Tuesday?
now you come with this?
no one is interested in this
without volume nothing is relevant
We need volume
I do not see it in this article?
FORM 10-Q
For the Quarter Ended December 31, 2020
Shares Outstanding
418,069,575
--------------------
FORM 10-Q
For the Quarter Ended March 31, 2021
Shares Outstanding
418,157,152
Numbers for those who are obsessed with dilution (Aspire, Kips Bay ...)
need,
you too?
https://www.ipharma.ru/klienty
we are on your customer list ...
they will last a short time
we will see...
if we get volume ... fly
I agree with you, ... credibility
I personally do not believe in ghosts, shorts, manipulation, MM etc, I can be wrong, but it is my opinion
But it is also true that expectations are not "trading higher" here, and we return again to .... credibility
We will have to wait for Julio
End of recruitment will not move this either
lowest closing of the year on January 13 0.1755$, yesterday 0.1762$
January 14 and 15 increased from 0.14$ to 0.23$ due to the FDA FAST TRACK DESIGNATION,
Since then a few good press releases to get us to 0.50$ and back to 0.17$, as if nothing had happened
April 28, 2021
INNOVATION PHARMA SURPASSES 50 PERCENT ENROLLMENT IN PHASE 2 CLINICAL TRIAL OF BRILACIDIN FOR COVID-19
April 14, 2021
INNOVATION PHARMA’S BROAD SPECTRUM ANTIVIRAL DRUG CANDIDATE BRILACIDIN HIGHLIGHTED IN BIODEFENSE AND INFECTIOUS DISEASES COVID-19 PRESENTATION
April 7, 2021
INNOVATION PHARMA ANNOUNCES BRILACIDIN ABSTRACT ACCEPTED FOR ORAL PRESENTATION AT THE AMERICAN SOCIETY FOR VIROLOGY’S ANNUAL MEETING
April 5, 2021
INNOVATION PHARMA COMPLETES INTERIM SAFETY DATA REVIEW—DMC APPROVES INCREASED DOSING FREQUENCY IN PHASE 2 CLINICAL TRIAL OF BRILACIDIN IN HOSPITALIZED COVID-19 PATIENTS
March 10, 2021
INNOVATION PHARMA’S COVID-19 DRUG CANDIDATE BRILACIDIN RANKED IN TOP THREE PERCENT OF COMPOUNDS PREDICTED TO BE MOST EFFECTIVE AGAINST SARS-COV-2
March 5, 2021
RECRUITMENT AND ENROLLMENT UNDERWAY AT EIGHT SITES FOR INNOVATION PHARMA’S PHASE 2 CLINICAL TRIAL OF BRILACIDIN FOR COVID-19
March 2, 2021
INNOVATION PHARMACEUTICALS ANNOUNCES PUBLICATION OF PEER-REVIEWED SCIENTIFIC ARTICLE IN THE JOURNAL VIRUSES ON THE ANTI-SARS-COV-2 PROPERTIES OF BRILACIDIN
February 26, 2021
INNOVATION PHARMA PROVIDES STUDY DETAILS FOR ONGOING PHASE 2 CLINICAL TRIAL OF BRILACIDIN IN HOSPITALIZED COVID-19 PATIENTS
January 29, 2021
INNOVATION PHARMACEUTICALS’ PHASE 2 CLINICAL TRIAL OF BRILACIDIN FOR TREATING COVID-19 SCHEDULED TO BEGIN NEXT WEEK
January 14, 2021
INNOVATION PHARMACEUTICALS’ BRILACIDIN FOR THE TREATMENT OF COVID-19 RECEIVES FDA FAST TRACK DESIGNATION
very close to the lows for the year (0.172$),
like nothing has happened since then,
frustrating
games, otherwise they wouldn't show it
agreements between MM
We will see, they have three vaccines: Sputnik-V, EpiVacCorona, CoviVac.
none are administered in the EU,
come on, and hardly any place with a serious regulatory agency
https://www.levante-emv.com/espana/2021/04/13/sputnik-v-solicitado-ema-estudiar-licencia-uso-47420999.html
I just think that it is not the best place to later seek the approval of the EMA, why not an EU country?
Why not directly seek the approval of the EMA in an EU country?
And why hasn't it?
The EMA will not approve anything that has been done in Russia.
If it is approved in Russia, they must request it from the EMA, provide the entire study, and go through another exam
waste of time
the EMA will approve any drug that is submitted for studies and is shown to be effective, but if the example is sputnik ... if they were transparent it would already be approved, like Jansen, Pfizer, Astrazeneca and Moderna
are you a fortune teller?
Nonsense? find out and watch sputnik I am European and it is not approved because they do not provide the documentation of the study to the EMA
because the tests are in Russia? Nothing from Russia will be approved by the European Union without going through the European Medicines Agency Example: Sputnik
any information about the company is here
I will not continue with this because it seems that either you are a blind follower or you become a detractor
we will continue to wait for phase II results
https://pharmamar.com/ciencia-e-innovacion/idi/
I hope you are right and that we have a joy as soon as possible
I am European, in Europe no one has heard of Brilacidin, it has never been on the cover of a newspaper, magazine or television.
Maybe Aplidin from Pharma Mar, approved Phase III.
Russia is not the European Union,
There we are doing the Phase II study almost completely
Nothing that can be approved in Russia will be used in Europe without prior approval from the European Medicines Agency and Russia is not an example of transparency
The European Medicines Agency has not approved the Sputnik vaccine because Russia does not provide the study data,
https://www.finanzas.com/ibex-35/phamamar-tendra-en-agosto-los-resultados-de-la-fase-iii-del-aplidin.html
https://www.economiadigital.es/galicia/politica/sanidad-da-por-hecha-la-aprobacion-del-aplidin-el-tratamiento-de-pharma-mar-contra-el-covid.html
I am Spanish, I know this company and I am very afraid that they will arrive before us wandering through Russia
"We turned to Russia because of the massive corruption here"
really? and we go to russia
where their approved vaccines are, nobody wants them, they don't provide studies to regulatory agencies
Are we going to Russia seeking justice?
There were many serious countries to do this,
But of course, with regulatory agencies ... SERIOUS ALSO
look at their vaccines, nobody puts them, except three desperate countries due to opacity
ok, but it is still an incongruity,
Russian government "official" website, No
Russian trial sites to treat patients, Si
is what has to have gone to Russia
I will never understand that for 120 patients, we have turned to Russia,
How can I forget, I can
but Russia accounts for 80% of the test
In the US there are three sites and they are recruiting in two, and how many patients would be from a test of 120?
few, very few for a PHII test, I think we will have to have everything finished, otherwise it would be insignificant
Loanranger?
silly question of the week:
We are recruiting in Russia and the US.
According to clinicaltrials.gov, 3 in the US and 11 in Russia.
https://clinicaltrials.gov/ct2/show/NCT04784897?term=brilacidin&draw=2&rank=2#contacts
In the United States, from three places, it is recruiting in two places.
In Russia in 9 of 11
now comes the question:
Because the end date on clinicaltrials.gov is July 2020 and in Russia several months later?
when does the test really end?
because ... the test is joint in both places
when we will have something that adds value,
this press article we all already knew
I am Spanish, Pharma Mar will lead Aplidin to success
The vaccines have arrived, the treatments will arrive,
that's why I think we are very slow in everything
We are at the minimum of the last 3 months,
Can someone explain to me if the price 0.2172 $ is the fault of criminals, shorts, BP and all other conspiracies,
I will put all my interest in understanding it,
My lack of knowledge does not allow me to understand this PPS in the situation in which we are
Pfizer will arrive with a pill and it's over
the acquaintances and four more and we would have 100%
I do not know whether to rejoice or despair
how slow!
https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html
We'll see, they have a vaccine and now ...
I do not understand any of this